1.
BHAVADHARANI S, VISWANATHAN A, BRAHMA N, S V, PUGAZHENDHI DT. ATORVASTATIN IN CEREBRAL CAVERNOUS MALFORMATION: ELUCIDATING ROCK INHIBITION AND LIPID-LOWERING MECHANISMS FOR THERAPEUTIC REPURPOSING. TPM [Internet]. 2025 Aug. 11 [cited 2026 Jun. 23];32(S1 (2025): Posted 12 May):396-9. Available from: https://tpmap.org/submission/index.php/tpm/article/view/185